American Heart Association (AHA) 2010 Scientific Sessions

Top News From AHA 2010: Slideshow
RAFT showed CRT confers survival benefit in class 2/3 heart failure; EMPHASIS-HF: eplerenone shows large benefits in mild HF; and DEFINE showed anacetrapib had large effects on LDL and HDL cholesterol.

• AHA ASCET: Single Antiplatelet Therapies Compared in Stable CAD
  Heartwire from Medscape, November 26, 2010
• AHA Low Levels of Troponin Predict HF, Death in Older Adults
  Heartwire from Medscape, November 26, 2010
• AHA Education Program Reduces STEMI-Symptom-to-Treatment Time
  Heartwire from Medscape, November 24, 2010
• AHA PROTECT: Adjust HF Meds to Achieve Natriuretic-Peptide Targets
  Heartwire from Medscape, November 24, 2010
• AHA Docs Misclassifying Two Thirds of Patients at High Risk for CV Events
  Heartwire from Medscape, November 24, 2010
• AHA PTSD Linked to Increased Risk of Death, Cardiovascular Disease
  Medscape Medical News, November 24, 2010
• AHA Xanthelasma Linked With MI and Ischemic Heart Disease
  Heartwire from Medscape, November 23, 2010
• AHA Coronary Calcium Weeds Out JUPITER-Like Patients
  Heartwire from Medscape, November 23, 2010
• AHA Cutting Salt by a Third Could Halve Hypertension Among Teens
  Heartwire from Medscape, November 23, 2010
• AHA ASCOT Analysis Fuels Debate Over JUPITER
  Heartwire from Medscape, November 19, 2010
• AHA Insurance Is Not the Only Issue in Access to Healthcare
  Heartwire from Medscape, November 19, 2010
• AHA ASSERT Trial
  Heartwire from Medscape, November 17, 2010
• AHA DEFINE at AHA
  Heartwire from Medscape, November 17, 2010
• AHA Interventionalists Tackle Resistant Hypertension With Renal Denervation
  Heartwire from Medscape, November 17, 2010
• AHA Heart Failure Remote Monitoring
  Heartwire from Medscape, November 17, 2010
• AHA REVEAL at the AHA
  Heartwire from Medscape, November 17, 2010
• AHA BASKET-PROVE Supports DES Safety
  Heartwire from Medscape, November 17, 2010
• AHA No Benefit of N-Acetylcysteine
  Heartwire from Medscape, November 17, 2010
• AHA FGF Gene Therapy Falls Short in Phase 3 Study of Critical Limb Ischemia
  Heartwire from Medscape, November 17, 2010
• AHA GRAVITAS: No Benefit of High-Dose Clopidogrel
  Heartwire from Medscape, November 16, 2010
• AHA CICERO: IC Abciximab in STEMI
  Heartwire from Medscape, November 16, 2010
• AHA Pharmacodynamics Back up PLATO Genetics Substudy
  Heartwire from Medscape, November 16, 2010
• AHA SMART-AV
  Heartwire from Medscape, November 15, 2010
• AHA PARTNER Quality-of-Life Analysis
  Heartwire from Medscape, November 15, 2010
• AHA CLOSURE I: Results Should "Ratchet Down" Closure Procedures
  Heartwire from Medscape, November 15, 2010
• AHA Vitamin D Deficiency Linked to Fatal Stroke in Whites But Not Blacks
  Medscape Medical News, November 15, 2010
• AHA Fish-Oil (Lovaza) Capsules Don't Suppress Paroxysmal AF
  Heartwire from Medscape, November 15, 2010
• AHA ROCKET-AF at AHA
  Heartwire from Medscape, November 15, 2010
• AHA Risk Guidelines Fail to Agree
  Heartwire from Medscape, November 15, 2010
• AHA Pulling the Plug Too Soon
  Heartwire from Medscape, November 14, 2010
• AHA Natrecor for Acute Decompensated HF
  Heartwire from Medscape, November 14, 2010
• AHA ADVANCE Study Shows HeartWare LVAD Non-Inferior tHeartMate II
  Heartwire from Medscape, November 14, 2010
• AHA EMPHASIS-HF: Eplerenone Shows Large Benefits in Milder Heart Failure
  Heartwire from Medscape, November 14, 2010
• AHA RAFT
  Heartwire from Medscape, November 14, 2010
• AHA Atrial Fibrillation Risk if First-Degree Relatives Have AF
  Heartwire from Medscape, November 13, 2010
• AHA AHA 2010: What's Going to Be Hot
  Heartwire from Medscape, November 9, 2010